key: cord-0981711-32i38tx3
authors: Du, Yanbin; Lv, Yuan; Zha, Wenting; Zhou, Nan; Hong, Xiuqin
title: Association of Body mass index (BMI) with Critical COVID-19 and in-hospital Mortality: a dose-response meta-analysis
date: 2020-09-16
journal: Metabolism
DOI: 10.1016/j.metabol.2020.154373
sha: 8b04ca8aa38c5313c758861d570e48eb6fef340f
doc_id: 981711
cord_uid: 32i38tx3

BACKGROUND AND PURPOSE: The coronavirus disease 2019 (COVID-19) pandemic presents an unprecedented health crisis to the entire world. As reported, the body mass index (BMI) may play an important role in COVID-19; however, this still remains unclear. The aim of this study was to explore the association between BMI and COVID-19 severity and mortality. METHODS: The Medline, PubMed, Embase and Web of science were systematically searched until August 2020. Random-effects models and dose-response meta-analysis were used to synthesize the results. Combined odds ratios (ORs) with their 95% confidence intervals (CIs) were calculated, and the effect of covariates were analyzed using subgroup analysis and meta-regression analyses. RESULTS: A total of 16 observational studies involving 109,881 patients with COVID-19 were included in the meta-analysis. The pooled results showed that patients with a BMI≥30kg/m(2) had a 2.35-fold risk(OR = 2.35, 95%CI = 1.64 − 3.38, P < 0.001) for critical COVID-19 and a 2.68-fold risk for COVID-19 mortality (OR = 2.68, 95%CI = 1.65 −4.37, P < 0.001 ) compared with patients with a BMI <30kg/m(2). Subgroup analysis results showed that patients with obesity and age > 60 years was associated with a significantly increased risk of critical COVID-19(OR = 3.11, 95%CI = 1.73 − 5.61, P < 0.001) and COVID-19 mortality(OR = 3.93, 95%CI = 2.18 − 7.09, P < 0.001). Meta-regression analysis results also showed that age had a significant influence on the association between BMI and COVID-19 mortality(Coef.=0.036, p=0.048). Random-effects dose-response meta-analysis showed a linear association between BMI and both critical COVID-19(P(non-linearity) = 0.242) and mortality (P(non-linearity) = 0.116). The risk of critical COVID-19 and mortality increased by 9%(OR = 1.09, 95%CI = 1.04 −1.14, P < 0.001) and 6%(OR = 1.06, 95%CI = 1.02 −1.10, P = 0.002) for each 1 kg/m(2) increase in BMI, respectively. CONCLUSIONS: Evidence from this meta-analysis suggested that a linear dose-response association between BMI and both COVID-19 severity and mortality. Further, obesity(BMI≥30kg/m(2)) was associated with a significantly increased risk of critical COVID-19 and in-hospital mortality of COVID-19.

The coronavirus disease 2019 pandemic has led to worldwide research efforts to identify individuals at greatest risk of developing critical illness and dying [1] . Initial data indicated that diabetes, cardiovascular disease, and respiratory or kidney disease were associated with an increased risk of adverse outcomes in patients with COVID-19 [2] [3] [4] . Increasing numbers of reports have linked obesity to more severe COVID-19 and mortality [5] [6] [7] [8] . However, existing studies, including epidemiological studies and meta-analyses, reported inconsistent results on the association between BMI and COVID-19.

In a French cohort study, the risk for invasive mechanical ventilation in patients with infection admitted to Intensive Treatment Unit was more than 7-fold higher for those with a BMI >35kg/m 2 compared with those with a BMI <25 kg/m 2 [9] . Among individuals with in New York, those with a BMI between 30-34 kg/m 2 and >35 kg/m 2 were 1.8 times and 3.6 times more likely to be admitted to critical care, respectively, than individuals with a BMI <30 kg/m 2 [10] .

Besides, the meta-analysis conducted by Yang et al. [11] and Soeroto et al. [12] revealed that patients with severe COVID-19 have a higher BMI than non-severe ones. However, Cai et al. reviewed a study in the Third People's Hospital of Shenzhen, Guangdong province, China, with 298 patients (aged 33-61 years) with COVID-19 and found no significant differences between non-severe (n=240) and severe (n=58) patients with the value of BMI being 22.9 kg/m 2 and 25.5 kg/m 2 , respectively [13] .

Thus, great differences were shown among existing studies. In addition, most conclusions were obtained from univariate estimates only and the sample size are also small. Whether obesity is an independent risk factor for COVID-19 and the dose-response association between BMI and the risk of severe COVID-19 and mortality are unclear.

Therefore, we conducted this meta-analysis to explore the association between BMI and COVID-19. Compared with the previously published meta-analyses, we herein performed a subgroup A dose-response analysis was also performed to further describe the relationship between BMI and critical COVID-19 and mortality using the method described by Orsini et al. (2012) [18] .

The potential nonlinear dose-response association between BMI and risk of critical COVID-19 and mortality was examined using a restricted cubic splines regression model with three knots at the 25th, 50th and 75th percentiles of the BMI distribution. We calculated the nonlinear P-value by testing the null hypothesis that the second spline coefficient is equal to zero [19] . Considering the heterogeneity among the studies, we performed a random-effect meta-analysis to calculate the trend based on the relevant logOR estimated across BMI levels. And a generalized least squares(GLS) regression was used to estimate the dose-response coefficients and 95%CIs. The median or mean BMI level in each category was assigned to the corresponding risk estimates of each study. If the BMI level was in a range, the midpoint of the upper and lower boundaries was considered the dose ; when the highest or lowest category was open-ended, we assumed the width between boundaries to be equal to that of the adjacent category.

To assess the potential publication bias, we used funnel plots and Egger's linear regression test [20] . Sensitivity analyses were conducted by excluding each study and reanalyzing the data. All statistical analyses were performed using STATA 15.0 (Stata Corp, Texas, USA). The significance level was set at P-values < 0.05, and all statistical tests were two-sided.

Our electronic literature search identified 2633 studies concerning effects of BMI(or obesity) on COVID-19, 2621 of which were excluded because of the following reasons. Firstly, 459 duplicated articles were excluded, then 2174 articles were screened by title and abstract, leading to exclusion of 1010 irrelevant studies and 1083 reports, reviews or meta-analysis, or letters. 7 The characteristics of the included studies and patients are shown in Tables 1 and 2. A total of 16 observational studies (14 cohort design and 2 cross-sectional design) that met the inclusion criteria for our meta-analysis were published from January to August 2020. Twelve studies explored the association between BMI and COVID-19 severity[8, [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] and seven studies explored the association between BMI and COVID-19 mortality[8, 23, [32] [33] [34] [35] . Of these studies, four were performed in Asia [24, 26, 28, 34] , including China(n=3) and Kuwait(n=1); Nine in America[8, 21, 23, 25, 27, [31] [32] [33] 35] , including USA (n=7) and Mexico (n=2); and three in Europe [22, 29, 30] , including Italy(n=2) and France(n=1). In total, 109,881 patients with COVID-19 were included in this meta-analysis, including critical(n=13,461), non-critical (n=82,296), death (n=2272), survivors (n=11852). Mean ages of the participants ranged from 32 to 70.5 years. Sample size ranged from 53 to 89756, the proportion of men ranged from 49% to 69.4%. Eight studies had more than three BMI categories[8, 21, 23, 24, [28] [29] [30] [31] ; the lowest dose of BMI was < 18 kg/m 2 , and the highest dose of BMI was > 40kg/m 2 . The NOS scores of all studies ranged from 4 to 9 points, and eight studies had a score of ≥ 7 points.

The effect of BMI on COVID-19 severity was explored from 12 studies (13,461 cases and 82,296 controls ). Heterogeneity test results revealed significant heterogeneity in these studies (Q = 77.24, P < 0.001, I 2 = 85.8%). And the random-effects model was applied, the summary OR for 12 studies showed that patients with a BMI≥30kg/m 2 was associated with a significantly increased risk(OR = 2.35, 95%CI = 1.64 − 3.38, P < 0.001 ) of developing into the critical condition compared to patients with a BMI <30kg/m 2 . (Figure 2 ( Table 4 )

A total of six studies [21, 23, 24, 25, 28, 29] were included in the dose-response meta-analysis of the association between BMI and critical COVID-19. It was found that there was a linear relationship (P non-linearity = 0.242) between BMI and the risk of critical COVID-19 (Figure 7) . And a 1.09-fold increased risk(OR = 1.09, 95%CI = 1.04 −1.14, P < 0.001 ) of critical COVID-19 for each J o u r n a l P r e -p r o o f Journal Pre-proof 1 kg/m 2 increase in BMI and a 1.19-fold increased risk(OR = 1.19, 95%CI = 1.08 −1.30, P < 0.001 ) of critical COVID-19 for each 2 kg/m 2 increase in BMI.

A total of four articles[8, 23, 30, 31] were included in the dose-response meta-analysis of the association between BMI and COVID-19 mortality. A linear dose-response relationship(P non-linearity = 0.116) was showed in Figure 8 . The mortality of patients with COVID-19 increased by 6%(OR = 1.06, 95%CI = 1.02 −1.10, P = 0.002 ) and 12%(OR = 1.12, 95%CI = 1.04 −1.21, P = 0.002 ) for each 1 kg/m 2 and 2 kg/m 2 increase in BMI, respectively.

Sensitivity analysis results showed that removal of each study did not significantly alter the overall effect of BMI≥30kg/m 2 on COVID-19 severity (OR altered between 1.71 and 3.59) and COVID-19 mortality (OR altered between 1.76 and 4.38). No publication bias was detected in current meta-analysis, although slight asymmetries were observed in the funnel plots, Egger's linear regression test were not statistically significant ( severity: P=0.665; mortality: P=0.139).

This meta-analysis explored the association between BMI and COVID-19 with a sample size of 109,881 individuals from 16 observational studies published in 2020. The evidence from this meta-analysis revealed that obesity(BMI≥30kg/m 2 ) was associated with a 2.35-fold risk of critical COVID-19 and a 2.68-fold risk of in-hospital mortality of COVID-19. This conclusions is consistent with the previous most studies, however, there are several new findings in our study, as indicated below.

Many epidemiological studies showed that obesity-related conditions seem to worsen the effect of COVID-19. However, most of these findings were obtained from univariate estimates only.

Several studies have shown that the pooled effects based on adjusted effect estimates were significantly reduced or even disappeared[8, 21, 27 ]. Thus, we conducted a meta-analysis based on the adjusted OR, although the pooled OR was significantly reduced in the multivariate analysis (OR = 1.69, 95%CI = 1.27 − 2.27) compared with that in the univariate analysis(OR = 5.15, 95%CI = 3.06 − 8.69), the results also showed that obesity was an independent risk factor for critical J o u r n a l P r e -p r o o f Journal Pre-proof . Similarly, the pooled results showed that obesity was an independent risk factor for COVID-19 mortality(OR = 3.34, 95%CI = 1.89 − 5.9). Meta-regression analysis results also showed that diabetes, hypertension and cardiovascular diseases did not exert significant effect on the association between obesity and COVID-19.

More interestingly, the dose-response analysis showed that with an increase in BMI, the risk of severe COVID-19 and death increased linearly. For each 1 kg/m 2 increase in BMI, the risk of critical COVID-19 and death increased by 9%(OR = 1.09, 95%CI = 1.04 −1.14) and 6%(OR = 1.06, 95%CI = 1.02 −1.10), respectively. Therefore, it can be inferred that severe obesity may be a strong risk factor for COVID-19. Kalligeros et al [21] have found that severe obesity (BMI ≥35 kg/m 2 ) was associated with a 5.39-fold risk of ICU admission(OR = 5.39, 95%CI = 1.13 −25.64). Palaiodimos et al [8] indicted that severe obesity(BMI≥35 kg/m 2 ) was independently associated with higher in hospital mortality(OR = 2.74, 95%CI = 1.25 −5.98). They also pointed out that this association remained significant even after adjusting for several clinical entities, such as diabetes, coronary artery disease, heart failure, cancer, or chronic kidney disease, and smoking, which indicates that severe obesity may predispose to negative outcomes independently.

The initial finding suggesting that at an older ages BMI is less important in influencing COVID-19 prognosis, because obesity was defined as a state of excess fat mass. And the BMI poorly describes excess fat mass in the elderly. However, subgroup analysis and meta-regression analyses results showed that age had a significant effect on the risk of critical COVID-19 and mortality.

Patients with obesity and age> 60 years had a near 4-fold higher risk of developing into the critical COVID-19 and dying. Lighter et al. [10] found that obesity (BMI ≥ 30 kg/m 2 ) was associated with a 1.5-fold risk of COVID-19 hospitalization in patients younger than 60 years and a 3.6-fold risk in patients older than 60 years. Moreover, a report from the USA showed that obesity was associated with a 4.5-fold risk of COVID-19 mortality in patients older than 60 years[8]. This may be because the elderly weight and muscle mass start to decline, and immune senescence. Obesity also has detrimental effects on lung function, diminishing forced expiratory volume and forced vital capacity, it is more harmful to the elderly individuals [36] . In addition, older patients with obesity are more prone to develop diabetes, hypertension and cardiovascular diseases, which are reported to be associated with an increased risk of COVID-19 severity [37, 38] .

Our study also found that COVID-19 patients with obesity in Asian countries had a higher risk of developing into a critical or mortal condition than patients in non-Asian countries. Asians have a different BMI cutoff (28 kg/m 2 ) to define obesity. Thus, Asians with a BMI ≥30 kg/m 2 are actually looking at patients that are more severely obese than Caucasian ones, this is a possible explanation for Asian studies reporting more severe outcomes in these patients. Cross-sectional studies showed a significantly higher effect of obesity on COVID-19 than cohort studies, and this may be attributed to the limited research data of only two cross-sectional studies.

In addition, a study from China reported that the risk of obesity to COVID-19 severity was more than 6-fold greater in those with metabolic associated fatty liver disease [24] . Simultaneously, several studies indicted that the association between obesity and COVID-19 severity may be related to smoking, but needs to be explored further [39] [40] . Moreover, emerging evidence suggests that visceral fat is a strong contributor to worse COVID-19 prognosis. Visceral adipose tissue is capable of secreting Interleukin 6 (IL-6), whose levels were found to be increased in SARS-CoV-2non-survivors. [41, 42] Although the pathophysiology underlying COVID-19-infection has not been completely 

This meta-analysis has several novelties. Firstly, our study showed that obesity was an independent risk factor for critical COVID-19 and mortality. Secondly, the dose-response meta-analysis showed a significant linear association between BMI and the risk of critical COVID-19 and mortality. Third, we found that patients with obesity and age> 60 years had a significantly higher COVID-19 mortality. Fourth, we performed multivariate subgroup and meta-regression analyses to fully explore the potential effect of confounding factors on the associations between obesity and COVID-19 severity and mortality.

Meanwhile, several potential limitations of our study deserve mention. Firstly, our study is limited with the small sample size of 16 studies, although we did not restricted our searches based on language, just studies from English databases and missed non-English articles may affect the final results. Secondly, different diagnostic criteria for obesity in Asia and non-Asia, which may be one of the sources of heterogeneity. Third, the majority of patients included in the meta-analysis were of America (mostly USA population), and it was not possible to test for ethnic-specific differences in risk of critical COVID-19 and COVID-19 linked death, because of the limited studies in no-America individuals. Thus, further studies, especially on European and Asian populations, are needed to confirm these findings, and future mechanistic studies are also required to better understand the link between BMI and the risk of severe disease and in-hospital mortality associated with COVID-19.

In conclusion, results from this meta-analysis indicate that obesity is associated with an increased risk of critical COVID-19 and mortality. Moreover, the dose-response analysis showed that with an increase in BMI, the risk of severe COVID-19 and mortality increased linearly. So, patients with both COVID-19 and obesity should be paid more attention to in hospitals, especially those with severe obesity or those older than 60 years. J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f Figure 6 . Random-effects meta-regression analysis to explore the effect of age on association between BMI>30kg/m 2 and COVID-19 severity(a) and mortality(b). 

The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health -The latest 2019 novel coronavirus outbreak in Wuhan, China

Cardiovascular disease potentially contributes to the progression and poor prognosis of covid-19. Nutrition Metabolism and Cardiovascular Diseases

Association of cardiovascular disease with coronavirus disease 2019 (covid-19) severity: a meta-analysis

Diabetes as a risk factor for greater covid-19 severity and in-hospital death: a meta-analysis of observational studies. Nutrition Metabolism and Cardiovascular Diseases

Relationship between COVID-19 and obesity

Obesity as a risk factor for greater severity of COVID-19 in patients with metabolic associated fatty liver disease

Aga Purwiga & Prayudi Santoso. Association of BMI and Obesity with Composite poor outcome in COVID-19 adult patients: A Systematic Review and Meta-Analysis

COVID-19 in a designated infectious diseases Hospital outside Hubei Province

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

Meta-analysis of observational studies in epidemiology: a proposal for reporting

Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

The Cochrane Collaboration's tool for assessing risk of bias in randomised trials

Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software

Chili consumption and risk of gastric cancer: a meta-analysis

Bias in meta-analysis detected by a simple, graphical test

Association of obesity with disease severity among patients with covid

Obesity and covid-19: an italian snapshot

Obesity is associated with worse outcomes in covid-19: analysis of early data from new york city

Obesity as a risk factor for greater

COVID-19: Impact of Obesity and Diabetes in Disease Severity. medRxiv

How important is obesity as a risk factor for respiratory failure, intensive care admission and death in hospitalised COVID-19 patients? Results from a single Italian centre

Risk Factors Associated with Severe COVID-19 in Eastern France: Analysis of 1045 Cases

Factors Associated with Hospitalization and Disease Severity in a Racially and Ethnically Diverse Population

Morbid obesity as an independent risk factor for covid-19 mortality in hospitalized patients younger than 50

Obesity is Associated with Increased Risk for Mortality Among Hospitalized Patients with COVID-19

Obesity predisposes to the risk of higher mortality in young covid patients

Early estimation of the risk factors for hospitalisation and mortality by COVID-19 in México

Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. Circulation

Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19, Nutrition, Metabolism and Cardiovascular Diseases

Association of Cardiovascular Disease with Coronavirus Disease 2019 (COVID-19) Severity: A Meta-Analysis, Current Problems in Cardiology

Clinical Characteristics of Coronavirus Disease 2019 in China

Tobacco smoking and COVID-19: an old enemy in a new guise. Review of current publications. Cardiovascular Therapy and Prevention

Kassir R. Risk of COVID-19 for patients with obesity. Obesity reviews: an official journal of the International Association for the Study of Obesity

Obesity Impairs the Adaptive Immune Response to Influenza Virus

Obesity and sars-cov-2: a population to safeguard

Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis

Random-effects dose-response meta-analysis showed a linear association between BMI and both severe COVID-19 and mortality